Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
259.96 USD  -3.68 (-1.40%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Lucrative AMD & DME Markets Attract Wall Street’s Attention
April 03, 2013
Lucrative AMD & DME Markets Attract Wall Street’s Attention One of the biggest success stories that we’ve seen in the history of recent drug launches was with the AMD (Age-related Macular Degeneration)... Read More
category RHHBY , REGN , AMPE , and 1 more.
from Bio-Wire.Com
Regeneron Pharmaceuticals, Inc. Larger Than S&P 500 Component Kroger Co.
April 01, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Regeneron Pharmaceuticals, Inc. (REGN) was identified as having a larger market cap than the smaller end of... Read More
category Stocks
from Market News Video
Cramer: This Growth Story Is Far From Over
March 28, 2013
The "Mad Money" host highlights a pharmaceutical stock that he thinks might produce considerable gains. Read More
category Regeneron Pharmaceuticals Inc , Mad Money , Investing/Exchanges/NASDAQ , and 2 more.
from CNBC.com News
Regeneron Pharmaceuticals Crosses Above its 10-day MA (REGN)
March 28, 2013
from Comtex SmarTrend® News Briefs
JMP Securities Starts Regeneron Pharma (REGN) at Market Perform
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8216764 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals Crosses Above its 10-day MA (REGN)
March 19, 2013
from Comtex SmarTrend® News Briefs
Cramer: 8 Top Performers Over Last 8 Years
March 15, 2013
Who says you can't beat the market. Had you picked stocks thoughtfully and carefully, since Mad Money began, you could have beaten the S&P by 3000%! Read More
category Regeneron Pharmaceuticals Inc , CRM Holdings Ltd/ , BioMarin Pharmaceutical Inc , and 23 more.
from CNBC.com News
Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)
March 14, 2013
 Read More
category NASDAQ:PCYC , NASDAQ:VRTX , NYSEARCA:XBI , and 2 more.
from InvestorPlace - Latest Headlines
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
March 12, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of February. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 33 more.
from Latest Articles from Benzinga.com
IJH, REGN, HFC, EQIX: Large Outflows Detected at ETF
March 11, 2013
Symbols mentioned in this story: IJH, REGN, HFC, EQIX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Merck's Big Vytorin Study Could Pose A Challenge For Amgen, Sanofi, And Regeneron, Too
March 08, 2013
Sometime this month, a group of independent experts will look at the data for the key study testing Merck's blockbuster cholesterol pills, Zetia and Vytorin. They could decide that the active... Read More
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
Drug Industry Executives Warn U.S. Must Reverse Cuts To Science Investment
March 06, 2013
 Read More
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
MDY, ENOR: Big ETF Outflows
March 05, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the SPDR S&P MidCap 400 ETF (MDY), which shed 2,400,000... Read More
category ETFs
from ETF Channel
Regeneron Pharmaceuticals Earnings In Retrospect: Up 1.5% in the Last 18 Days (REGN)
March 04, 2013
from Comtex SmarTrend® News Briefs
Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials
March 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8150053 for the full story. Read More
from StreetInsider.com News Articles
Sanofi, Regeneron Report Positive Phase 1b Data for Dupilumab in Atopic Dermatitis
March 02, 2013
Sanofi (NYSE: SNY ) and Regeneron Pharmaceuticals (NASDAQ: REGN ) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity,... Read More
category Management , Benzinga , REGN , and 5 more.
from Latest Articles from Benzinga.com
The New #19 Most Shorted Nasdaq 100 Component: Vertex Pharmaceuticals, Inc.
March 01, 2013
The most recent short interest data was released this week by the NASDAQ for the 02/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the... Read More
category Stocks
from Market News Video
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
February 28, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ),... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Barclays Starts Regeneron Pharma (REGN) at Overweight
February 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8141054 for the full story. Read More
from StreetInsider.com News Articles
Top Analyst Upgrades and Downgrades (BSFT, DB, EBAY, EIX, FSLR, GRPN, JCP, RHT, REGN, SKS, UBS, VSI, VMW)
February 28, 2013
DailyFinance.com : These are some of this Thursday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Broadsoft Inc. (NASDAQ: BSFT) downgraded after poor expense... Read More
category grpn , eix , ebay , and 10 more.
from DailyFinance.com
Post Earnings Update: Regeneron Pharmaceuticals Has Sunk 5.2% Lower in Past Week (REGN)
February 25, 2013
from Comtex SmarTrend® News Briefs
The Week in Review: Reckitt Benckiser Buys Anhui’s Golong Medicine
February 23, 2013
Reckitt Benckiser, a British maker of OTC drugs, acquired Golong Medicine of Anhui, a TCM company that will provide a base for Reckitt Benckiser’s products in China; China’s SFDA announced a set of... Read More
from ChinaBio® Today
Regeneron and Bayer Start Phase III Trial of Macular Edema Drug in China
February 19, 2013
Regeneron Pharmaceuticals and Bayer HealthCare have started a new Phase III trial to test Eylea® (aflibercept) Injection as a treatment for Diabetic Macular Edema (DME). The trial will be conducted in... Read More
from ChinaBio® Today
UPDATE 2-Regeneron profit beats Street on Eylea sales strength
February 14, 2013
Feb 14 (Reuters) - Regeneron Pharmaceuticals Inc on Thursday reported a profit that exceeded Wall Street estimates for the sixth consecutive quarter as sales of its new Eylea eye drug for the leading... Read More
category companyNews
from Reuters: Company News
iShares Core S&P Mid-Cap ETF Experiences Big Inflow
February 14, 2013
Symbols mentioned in this story: IJH, REGN, EQIX, VRTX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Regeneron Pharmaceuticals, Inc. (REGN) Tops Q4 EPS by 36c
February 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8094951 for the full story. Read More
from StreetInsider.com News Articles
A Better Way to Use BlackRock’s Core ETFs
February 14, 2013
 Read More
category NYSE:KRC , Retirement , NASDAQ:REGN , and 3 more.
from InvestorPlace - Latest Headlines
Earnings Scheduled For February 14, 2013
February 14, 2013
Alexion Pharmaceuticals (NASDAQ: ALXN ) is expected to report its Q4 earnings at $0.53 per share on revenue of $316.49 million. General Motors Company (NYSE: GM ) is estimated to report its Q4 earnings... Read More
category SPW , Earnings , Benzinga , and 38 more.
from Latest Articles from Benzinga.com
Celgene, Regeneron Get Some Favorable News
February 13, 2013
News of a stock purchase and a product breakthrough jolted shares of two of the major biotech stocks Monday. Shares of Regeneron Pharmaceuticals (REGN) rose 3% in nearly three times their average... Read More
category IBD Industry Themes
from Investor's Business Daily - Investing RSS
Trading Radar for 02/14: General Motors (GM), CBS (CBS), DirecTV (DTV), Pepsi (PEP), Orbitz (OWW) Report
February 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8093311 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here